CANCER BIOSTATISTICS SHARED RESOURCE ABSTRACT The Cancer Biostatistics (CB) Shared Resource provides state-of-the-art biostatistics and research design support to laboratory, translational, clinical, and population sciences investigators at Huntsman Cancer Institute (HCI). It is a section of the University of Utah (U of U) Study Design and Biostatistics Center (SDBC), the biostatistics core of the U of U Health Sciences Center and its National Institutes of Health Clinical and Translational Science Award-supported Center for Clinical and Translational Science (CCTS). The CB Shared Resource is led by Kenneth Boucher, PhD, an accomplished biostatistician and a Cancer Center member since 1996, and includes five personnel with specialized cancer research expertise. Dr. Boucher works in close coordination with Tom Greene, PhD, SDBC Director, a senior biostatistician with more than 25 years of experience serving as the lead statistician for NIH- and industry-sponsored multi-center clinical trials and other large-scale multidisciplinary research efforts. The CB Shared Resource arranges statistical teams to support all stages of the research process to benefit Cancer Center members, providing HCI researchers with integrated statistical and epidemiologic expertise in study design, health measurement, and data analysis. This expertise includes clinical trial and observational study design, longitudinal data analysis, linear and nonlinear mixed effects models, survival analysis, multivariate methods, meta-analysis, Bayesian models, computational statistics, diagnostic testing, comparative effectiveness research, modern causal inference, survey design and questionnaire development, item response theory and computer adaptive testing, and statistical genetics and genomics. In addition to providing statistical analyses, the CB Shared Resource provides guidance in formulation of research objectives, development of informative and efficient study designs, implementation of randomized procedures, design and implementation of surveys, selection of appropriate instruments and development of new instruments for measurement of health outcomes, development of appropriate procedures for collection and secure storage of data, collaborative formulation of pre-specified analysis plans prior to data analysis, and interpretation and presentation of data in publications and oral presentations. The CB Shared Resource is located in the HCI building, providing direct on-site access to resource users throughout all stages of the research process. The importance of the CB Shared Resource is demonstrated by its wide array of users and its contributions to numerous publications, many in high-profile journals. In 2013, use of the CB Shared Resource by Cancer Center investigators with peer-reviewed funding exceeded 66%, while the CCSG budget request is only 6% ($46,388) of the total proposed budget.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-29
Application #
9478883
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
29
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Tavtigian, Sean V; Greenblatt, Marc S; Harrison, Steven M et al. (2018) Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Genet Med 20:1054-1060
Rogers, R Aaron; Fleming, Aaron M; Burrows, Cynthia J (2018) Unusual Isothermal Hysteresis in DNA i-Motif pH Transitions: A Study of the RAD17 Promoter Sequence. Biophys J 114:1804-1815
Rogers, R Aaron; Fleming, Aaron M; Burrows, Cynthia J (2018) Rapid Screen of Potential i-Motif Forming Sequences in DNA Repair Gene Promoters. ACS Omega 3:9630-9635
Wei, Xiaomu; Calvo-Vidal, M Nieves; Chen, Siwei et al. (2018) Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma. Cancer Res 78:2747-2759
Barrott, Jared J; Illum, Benjamin E; Jin, Huifeng et al. (2018) Paracrine osteoprotegerin and ?-catenin stabilization support synovial sarcomagenesis in periosteal cells. J Clin Invest 128:207-218
Sample, Danielle C; Samadder, N Jewel; Pappas, Lisa M et al. (2018) Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients. BMC Gastroenterol 18:115
Delker, Don A; Wood, Austin C; Snow, Angela K et al. (2018) Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia. Cancer Prev Res (Phila) 11:4-15
Madsen, Michael J; Knight, Stacey; Sweeney, Carol et al. (2018) Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15. Cancer Epidemiol Biomarkers Prev 27:644-652
Trott, Daniel W; Henson, Grant D; Ho, Mi H T et al. (2018) Age-related arterial immune cell infiltration in mice is attenuated by caloric restriction or voluntary exercise. Exp Gerontol 109:99-107
Wu, Yelena P; Parsons, Bridget G; Mooney, Ryan et al. (2018) Barriers and Facilitators to Melanoma Prevention and Control Behaviors Among At-Risk Children. J Community Health 43:993-1001

Showing the most recent 10 out of 1193 publications